Tumor-protein 53 (p53) is a transcription factor (TF) encoded by TP53 (Trp53 in mice) and is a master regulator of tumor-suppressive programs. Importantly, TP53 is the most frequently mutated gene in human cancer, and its loss of function contributes to tumor development, exemplified by variable p53 mutations detected in 50%-75% of pancreatic cancers. From these perceptions, a number of targets transcribed by p53 that confer tumor suppression have been identified. Nevertheless, our understanding of how p53 prevents normal cells from initiating tumorigenesis is still incomplete. To complement this limitation, herein, we established a new approach to identify underlying effectors transcribed by p53 in normal physiology.